Fund+ Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 28
  • Portfolio
  • 16
  • Exits
  • 5
Exits

Fund+ General Information

Description

Founded in 2015, Fund+ is a venture capital firm that is based in Leuven, Belgium. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm prefers to invest in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors in Belgium.

Contact Information

Website
www.fundplus.be
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Groot Begijnhof 60
  • 3000 Leuven
  • Belgium
+32 016 00 00 00

Fund+ Investments (28)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Egle Therapeutics 22-Oct-2021 Early Stage VC 000.00 Drug Discovery Startup 00000000 00000000 00.0
0000000 30-Sep-2021 00000 00000 000.00 Biotechnology Generating Revenue 00000000 00000000 00.0
0000000 25-Aug-2021 00000 00000 000.00 Pharmaceuticals Generating Revenue 000 000 000 0000000
00000 000000000000 21-Jul-2021 00000 00000 000.00 Drug Delivery Generating Revenue 00000000 00000000 00.0
0000000000 0000000 30-Jun-2021 00000 00000 000.00 Drug Discovery Generating Revenue
000000 000 16-Mar-2021 00000 00000 000.00 Drug Discovery Generating Revenue 00000000 00000000 00.0
0000000 15-Aug-2020 00000 00000 000.00 Drug Discovery Generating Revenue 00000000 00000000 00.0
000000 27-Jul-2020 00000 00000 0000 Monitoring Equipment Generating Revenue 000 000 000 0000000
Ona Therapeutics 16-Jun-2020 Early Stage VC 000.00 Drug Discovery Generating Revenue 000000000 00000 00.0
eTheRNA Immunotherapies 16-Jun-2020 Later Stage VC 000.00 Drug Discovery Clinical Trials - General 000000000 00000 00.0
You’re viewing 10 of 28 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fund+ Exits (5)

Company Name Exit Date Exit Type Exit Size
iTeos Therapeutics 24-Jul-2020 IPO 00000
0000000 0000000000 12-Apr-2019 0000000 000000
00000 16-May-2017 000000000000000000 00000
AmatsiQBiologicals 25-Jan-2016 Buyout/LBO
Masthercell 27-Feb-2015 Merger/Acquisition 000.00
To view Fund+’s complete exits history, request access »

Fund+ Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Fund+ Team (7)

Name Title Deals Funds Boards Office
Chris Buyse Managing Partner and Executive Board Member 0 0 Leuven, Belgium
Alexandra Tolia Ph.D Partner 00 0 0 Leuven, Belgium
Philippe Monteyne Ph.D Partner 0 0 Leuven, Belgium
Desire Collen Ph.D Founder & Chairman 0 0 Leuven, Belgium
Louise Declerck MD Associate 0 Leuven, Belgium
You’re viewing 5 of 7 team members. Get the full list »